Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
1.870
-0.250 (-11.79%)
At close: Mar 28, 2025, 4:00 PM
1.702
-0.168 (-8.98%)
After-hours: Mar 28, 2025, 7:55 PM EDT

Skye Bioscience Statistics

Total Valuation

Skye Bioscience has a market cap or net worth of $57.92 million. The enterprise value is -$10.04 million.

Market Cap 57.92M
Enterprise Value -10.04M

Important Dates

The last earnings date was Thursday, March 20, 2025, after market close.

Earnings Date Mar 20, 2025
Ex-Dividend Date n/a

Share Statistics

Skye Bioscience has 30.97 million shares outstanding. The number of shares has increased by 420.79% in one year.

Current Share Class 30.97M
Shares Outstanding 30.97M
Shares Change (YoY) +420.79%
Shares Change (QoQ) +2.96%
Owned by Insiders (%) 2.99%
Owned by Institutions (%) 41.84%
Float 15.69M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.85
P/TBV Ratio 0.85
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 16.32, with a Debt / Equity ratio of 0.01.

Current Ratio 16.32
Quick Ratio 15.77
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -40.30

Financial Efficiency

Return on equity (ROE) is -80.48% and return on invested capital (ROIC) is -53.09%.

Return on Equity (ROE) -80.48%
Return on Assets (ROA) -44.56%
Return on Invested Capital (ROIC) -53.09%
Return on Capital Employed (ROCE) -44.13%
Revenue Per Employee n/a
Profits Per Employee -$2.42M
Employee Count 11
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, Skye Bioscience has paid $10,071 in taxes.

Income Tax 10,071
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -86.96% in the last 52 weeks. The beta is 1.71, so Skye Bioscience's price volatility has been higher than the market average.

Beta (5Y) 1.71
52-Week Price Change -86.96%
50-Day Moving Average 2.73
200-Day Moving Average 4.53
Relative Strength Index (RSI) 34.83
Average Volume (20 Days) 197,286

Short Selling Information

The latest short interest is 2.06 million, so 6.64% of the outstanding shares have been sold short.

Short Interest 2.06M
Short Previous Month 2.17M
Short % of Shares Out 6.64%
Short % of Float 13.10%
Short Ratio (days to cover) 14.81

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -30.19M
Pretax Income -42.28M
Net Income -26.57M
EBITDA -29.90M
EBIT -30.19M
Earnings Per Share (EPS) -$0.73
Full Income Statement

Balance Sheet

The company has $68.42 million in cash and $455,590 in debt, giving a net cash position of $67.96 million or $2.19 per share.

Cash & Cash Equivalents 68.42M
Total Debt 455,590
Net Cash 67.96M
Net Cash Per Share $2.19
Equity (Book Value) 68.15M
Book Value Per Share 2.20
Working Capital 66.49M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$25.24 million and capital expenditures -$1.60 million, giving a free cash flow of -$26.84 million.

Operating Cash Flow -25.24M
Capital Expenditures -1.60M
Free Cash Flow -26.84M
FCF Per Share -$0.87
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Skye Bioscience does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -420.79%
Shareholder Yield n/a
Earnings Yield -45.87%
FCF Yield -46.34%

Analyst Forecast

The average price target for Skye Bioscience is $18.00, which is 862.57% higher than the current price. The consensus rating is "Buy".

Price Target $18.00
Price Target Difference 862.57%
Analyst Consensus Buy
Analyst Count 7
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) 29.71%
Stock Forecasts

Stock Splits

The last stock split was on September 8, 2023. It was a reverse split with a ratio of 0.004:1.

Last Split Date Sep 8, 2023
Split Type Reverse
Split Ratio 0.004:1

Scores

Altman Z-Score n/a
Piotroski F-Score 2